{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:12:36Z","timestamp":1787497956867,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Assessing the experiences of individuals on methadone treatment is essential to help evaluate the treatment program\u2019s effectiveness. This study aimed to explore the experiences of patients receiving methadone treatment at a clinic in Nairobi, Kenya.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This study employed an exploratory qualitative study design. Through purposive sampling, participants were enrolled from individuals attending a methadone clinic for at least 2\u00a0years. Semi-structured individual interviews were used to collect data on substance use and experience before methadone treatment and experiences after starting methadone treatment, including benefits and challenges. Interviews were transcribed, and NVIVO 12 software was used to code the data using the preidentified analytical framework. Thematic analyses were utilized to identify cross-cutting themes between these two data sets. Seventeen participants were enrolled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventeen participants were enrolled comprising 70% males, with age range from 23 to 49\u00a0years and more than half had secondary education. The interview data analysis identified four themes, namely: (a) the impact of opioid use before starting treatment which included adverse effects on health, legal problems and family dysfunction; (b) learning about methadone treatment whereby the majority were referred from community linkage programs, family and friends; (c) experiences with care at the methadone treatment clinic which included benefits such as improved health, family reintegration and stigma reduction; and (d) barriers to optimal methadone treatment such as financial constraints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings of this study show that clients started methadone treatment due to the devastating impact of opioid use disorder on their lives. Methadone treatment allowed them to regain their lives from the adverse effects of opioid use disorder. Additionally, challenges such as financial constraints while accessing treatment were reported. These findings can help inform policies to improve the impact of methadone treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-022-00352-z","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:08:56Z","timestamp":1670803736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7296-7216","authenticated-orcid":false,"given":"Sarah Kanana","family":"Kiburi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackline","family":"Mwangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Maina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"352_CR1","doi-asserted-by":"publisher","DOI":"10.18356\/9789210019545","volume-title":"World drug report 2022: global overview drug demand drug supply","author":"United Nations office on drug and crime (UNODC)","year":"2022","unstructured":"United Nations office on drug and crime (UNODC). World drug report 2022: global overview drug demand drug supply. New York: United Nations Publ; 2022."},{"issue":"10208","key":"352_CR2","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","volume":"394","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Series drug use 1 global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560\u201379. https:\/\/doi.org\/10.1016\/S0140-6736(19)32229-9.","journal-title":"Lancet"},{"key":"352_CR3","doi-asserted-by":"publisher","DOI":"10.18356\/27bc31a5-en","volume-title":"World drug report 2020: drug use and health consequences","author":"United Nations Office on Drugs and Crime U","year":"2020","unstructured":"United Nations Office on Drugs and Crime. World drug report 2020: drug use and health consequences. Austria: United Nations publication; 2020."},{"key":"352_CR4","volume-title":"Opioid overdose: preventing and \u00adreducing opioid overdose mortality","author":"United Nations Office on Drugs and Crime U and WHO","year":"2013","unstructured":"United Nations Office on Drugs and Crime and World Health Organization (WHO). Opioid overdose: preventing and \u00adreducing opioid overdose mortality. Vienna: United Nations; 2013."},{"key":"352_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1186\/1471-2458-12-882","volume":"12","author":"CR Pischke","year":"2012","unstructured":"Pischke CR, Zeeb H, van Hal G, Vriesacker B, McAlaney J, Bewick BM, et al. A feasibility trial to examine the social norms approach for the prevention and reduction of licit and illicit drug use in European university and college students. BMC Public Health. 2012;12:882.","journal-title":"BMC Public Health"},{"issue":"9","key":"352_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40273-016-0400-5","volume":"34","author":"SM Murphy","year":"2016","unstructured":"Murphy SM, Polsky D. Economic evaluations of opioid use disorder interventions: a systematic review HHS public access. Pharmacoeconomics. 2016;34(9):863\u201387.","journal-title":"Pharmacoeconomics."},{"issue":"4","key":"352_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s40429-018-0232-9","volume":"5","author":"AE Kurth","year":"2018","unstructured":"Kurth AE, Cherutich P, Conover R, Chhun N, Bruce RD, Lambdin BH. The opioid epidemic in Africa and its impact. Curr Addict Rep. 2018;5(4):428\u201353.","journal-title":"Curr Addict Rep"},{"issue":"1","key":"352_CR8","first-page":"1","volume":"1","author":"NACADA","year":"2017","unstructured":"NACADA. Rapid situation assessment of drugs and substance abuse in Kenya. NACADA Rep. 2017;1(1):1\u2013119.","journal-title":"NACADA Rep"},{"issue":"1","key":"352_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-018-1780-1","volume":"18","author":"SK Kiburi","year":"2018","unstructured":"Kiburi SK, Molebatsi K, Obondo A, Kuria MW. Adverse childhood experiences among patients with substance use disorders at a referral psychiatric hospital in Kenya. BMC Psychiatry. 2018;18(1):1\u201312.","journal-title":"BMC Psychiatry"},{"issue":"17","key":"352_CR10","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1080\/14656566.2016.1244529","volume":"17","author":"D Ayanga","year":"2016","unstructured":"Ayanga D, Shorter D, Kosten TR. Update on pharmacotherapy for treatment of opioid use disorder. Expert Opin Pharmacother. 2016;17(17):2307\u201318. https:\/\/doi.org\/10.1080\/14656566.2016.1244529.","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"352_CR11","doi-asserted-by":"publisher","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","volume":"5","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Heal. 2017;5(12):e1208\u201320.","journal-title":"Lancet Glob Heal"},{"issue":"1","key":"352_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-017-0205-7","volume":"15","author":"JL Burgos","year":"2018","unstructured":"Burgos JL, Cepeda JA, Kahn JG, Mittal ML, Meza E, Lazos RRP, et al. Cost of provision of opioid substitution therapy provision in Tijuana. Mexico Harm Reduct J. 2018;15(1):1\u20138.","journal-title":"Mexico Harm Reduct J"},{"issue":"3","key":"352_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0924-9338(12)00031-4","volume":"27","author":"A Kheradmand","year":"2012","unstructured":"Kheradmand A, Hedayati N, Bannazadeh N, Abedi H. P-46\u2014physical effects of methadone maintenance treatment from the standpoint of clients. Eur Psychiatry. 2012;27(3):1.","journal-title":"Eur Psychiatry"},{"issue":"1","key":"352_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-018-0787-z","volume":"17","author":"M Khazaee-Pool","year":"2018","unstructured":"Khazaee-Pool M, Moeeni M, Ponnet K, Fallahi A, Jahangiri L, Pashaei T. Perceived barriers to methadone maintenance treatment among Iranian opioid users. Int J Equity Health. 2018;17(1):1\u201310.","journal-title":"Int J Equity Health"},{"key":"352_CR15","unstructured":"International Harm Reduction. Global state of harm reduction: 2019 updates. Harm Reduct Int. 2019;1\u201363. https:\/\/www.hri.global\/global-state-of-harm-reduction-2019."},{"issue":"25","key":"352_CR16","first-page":"1","volume":"17","author":"M Marks","year":"2020","unstructured":"Marks M, Scheibe A, Shelly S. High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion. Harm Reduct J. 2020;17(25):1\u201314.","journal-title":"Harm Reduct J"},{"key":"352_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijerph16050728","volume":"16","author":"S Hassan","year":"2019","unstructured":"Hassan S, Cooke A, Saleem H, Mushi D, Mbwambo J, Lambdin BH. Evaluating the integrated methadone and anti-retroviral therapy strategy in tanzania using the RE-AIM framework. Int J Environ Res Public Health. 2019;16:5.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"352_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/17441692.2015.1046385","volume":"10","author":"T Rhodes","year":"2015","unstructured":"Rhodes T, Ndimbii J, Guise A, Cullen L, Ayon S. Navigating the poverty of heroin addiction treatment and recovery opportunity in Kenya: access work, self-care and rationed expectations. Glob Public Health. 2015;10(7):867\u201380.","journal-title":"Glob Public Health"},{"key":"352_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108587","author":"LW Mbogo","year":"2021","unstructured":"Mbogo LW, Sambai B, Monroe-Wise A, Ludwig-Barron NT, Guthrie BL, Bukusi D, et al. Participation in methadone programs improves antiretroviral uptake and HIV viral suppression among people who inject drugs in Kenya. J Subst Abuse Treat. 2021. https:\/\/doi.org\/10.1016\/j.jsat.2021.108587.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"352_CR20","doi-asserted-by":"publisher","first-page":"e007198","DOI":"10.1136\/bmjopen-2014-007198","volume":"5","author":"T Rhodes","year":"2015","unstructured":"Rhodes T, Guise A, Ndimbii J, Strathdee S, Ngugi E, Platt L, et al. Is the promise of methadone Kenya\u2019s solution to managing HIV and addiction? a mixed-method mathematical modelling and qualitative study. BMJ Open. 2015;5(3):e007198.","journal-title":"BMJ Open"},{"issue":"2","key":"352_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/heapol\/czz002","volume":"34","author":"A Guise","year":"2019","unstructured":"Guise A, Ndimbii J, Igonya EK, Owiti F, Strathdee SA, Rhodes T. Integrated and differentiated methadone and HIV care for people who use drugs: a qualitative study in Kenya with implications for implementation science. Heal Policy Plan. 2019;34(2):110\u20139.","journal-title":"Heal Policy Plan"},{"key":"352_CR22","first-page":"12","volume":"4","author":"A Guise","year":"2015","unstructured":"Guise A, Dimova M, Ndimbii J, Clark P, Rhodes T. A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction. Harm Reduct J. 2015;4:12.","journal-title":"Harm Reduct J"},{"issue":"2","key":"352_CR23","first-page":"95","volume":"14","author":"J Ndimbii","year":"2015","unstructured":"Ndimbii J, Guise A, Ayon S, Kalama M, McLean S, Rhodes T. Implementing needle and syringe programmes in Kenya: changes, opportunities and challenges in HIV prevention. Afr J Drug Alcohol Stud. 2015;14(2):95\u2013103.","journal-title":"Afr J Drug Alcohol Stud"},{"issue":"6","key":"352_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12199-016-0570-y","volume":"21","author":"W Li","year":"2016","unstructured":"Li W, Wang Z, Liu Z. Factors associated with illicit opioid use in methadone maintenance treatment clients in 5 Provinces China. Environ Health Prev Med. 2016;21(6):480\u20136.","journal-title":"Environ Health Prev Med"},{"issue":"1","key":"352_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/qhw.v11.31992","volume":"11","author":"TE Gr\u00f8nnestad","year":"2016","unstructured":"Gr\u00f8nnestad TE, Sagvaag H. Stuck in limbo: illicit drug users\u2019 experiences with opioid maintenance treatment and the relation to recovery. Int J Qual Stud Health Well-being. 2016;11(1):1\u201311.","journal-title":"Int J Qual Stud Health Well-being"},{"issue":"117","key":"352_CR26","first-page":"1","volume":"13","author":"N Gale","year":"2013","unstructured":"Gale N, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(117):1\u20138.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"352_CR27","first-page":"14","volume":"3","author":"LP Wong","year":"2008","unstructured":"Wong LP. Data analysis in qualitative research: a brief guide to using NVIVO. Malays Fam Physician. 2008;3(1):14\u201320.","journal-title":"Malays Fam Physician"},{"key":"352_CR28","doi-asserted-by":"publisher","first-page":"107618","DOI":"10.1016\/j.drugalcdep.2019.107618","volume":"206","author":"MS Ellis","year":"2020","unstructured":"Ellis MS, Kasper ZA, Cicero TJ. The impact of opioid use disorder on levels of educational attainment: perceived benefits and consequences. Drug Alcohol Depend. 2020;206:107618.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"352_CR29","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.5001\/omj.2020.07","volume":"35","author":"M Moradinazar","year":"2020","unstructured":"Moradinazar M, Farnia V, Alikhani M, Karyani AK, Rezaei S, Rezaeian S, et al. Factors related to relapse in patients with substance-related disorders under methadone maintenance therapy: decision tree analysis. Oman Med J. 2020;35(1):e89.","journal-title":"Oman Med J"},{"key":"352_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13011-020-00300-7","volume":"15","author":"E Afuseh","year":"2020","unstructured":"Afuseh E, Pike CA, Oruche UM. Individualized approach to primary prevention of substance use disorder: age- related risks. Subst Abus Treat Prev Policy. 2020;15:58.","journal-title":"Subst Abus Treat Prev Policy"},{"issue":"53","key":"352_CR31","first-page":"s185","volume":"109","author":"W Compton","year":"2019","unstructured":"Compton W, Jones C, Baldwin G, Harding F, Blanco C, Wango E. Targeting youth to prevent later substance use disorder: an underutilized response to the us opioid crisis. AJPH Perspect. 2019;109(53):s185-189.","journal-title":"AJPH Perspect"},{"key":"352_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","volume":"161","author":"G Kourounis","year":"2016","unstructured":"Kourounis G, David B, Richards W, Kyprianou E, Symeonidou E, Malliori M, et al. Opioid substitution therapy: lowering the treatment thresholds. Drug Alcohol Depend. 2016;161:1\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.021.","journal-title":"Drug Alcohol Depend"},{"key":"352_CR33","doi-asserted-by":"publisher","DOI":"10.3147\/202004b","author":"BK Madras","year":"2020","unstructured":"Madras BK, Hospital M, Ahmad NJ. Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system. Perspect Expert Voices Heal Care. 2020. https:\/\/doi.org\/10.3147\/202004b.","journal-title":"Perspect Expert Voices Heal Care"},{"key":"352_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/1472-6963-13-412","volume":"13","author":"BB Mutamba","year":"2013","unstructured":"Mutamba BB, van Ginneken N, Smith Paintain L, Wandiembe S, Schellenberg D. Roles and effectiveness of lay community health workers in the prevention of mental, neurological and substance use disorders in low and middle income Countries: a systematic review. BMC Health Serv Res. 2013;13:412.","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"352_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.amjmed.2012.11.031","volume":"126","author":"S Bowman","year":"2013","unstructured":"Bowman S, Eiserman J, Beletsky L, Stancliff S, Bruce RD. Reducing the health consequences of opioid addiction in primary care. Am J Med. 2013;126(7):565\u201371.","journal-title":"Am J Med"},{"key":"352_CR36","volume-title":"Kenya AIDS strategic framework 2014\/2015- 2018\/2019","author":"National AIDS Control Council","year":"2014","unstructured":"National AIDS Control Council. Kenya AIDS strategic framework 2014\/2015- 2018\/2019. New Delhi: Natl AIDS Control Counc; 2014."},{"issue":"1\u20132","key":"352_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.drugalcdep.2011.12.008","volume":"124","author":"M Kidorf","year":"2012","unstructured":"Kidorf M, King VL, Gandotra N, Kolodner K, Brooner RK. Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12\u00a0Month outcomes. Drug Alcohol Depend. 2012;124(1\u20132):162\u20136. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.12.008.","journal-title":"Drug Alcohol Depend"},{"key":"352_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/1178221816685087","author":"J Woo","year":"2017","unstructured":"Woo J, Bhalerao A, Bawor M, Bhatt M, Dennis B, Mouravska N, et al. \u201cDon\u2019t judge a book by its cover\u201d: a qualitative study of methadone patients\u201d experiences of stigma. Substance Abuse: Treatment and Research, 2017: 1\u201312. https:\/\/doi.org\/10.1177\/1178221816685087.","journal-title":"Subst Abuse"},{"key":"352_CR39","first-page":"1","volume":"2","author":"L Moran","year":"2018","unstructured":"Moran L, Keenan E, Elmusharaf K. Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland\u2019 s drug and alcohol services. BMC Health Serv Res, 2018:18:911","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"352_CR40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s40501-016-0090-9","volume":"3","author":"CG Sch\u00fctz","year":"2016","unstructured":"Sch\u00fctz CG. Homelessness and addiction: causes, consequences and interventions. Curr Treat Options Psychiatry. 2016;3(3):306\u201313. https:\/\/doi.org\/10.1007\/s40501-016-0090-9.","journal-title":"Curr Treat Options Psychiatry"},{"issue":"9953","key":"352_CR41","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(14)61133-8","volume":"384","author":"SW Hwang","year":"2014","unstructured":"Hwang SW, Burns T. Health interventions for people who are homeless. Lancet. 2014;384(9953):1541\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(14)61133-8.","journal-title":"Lancet"},{"issue":"3","key":"352_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1360-0443.2011.03676.x","volume":"107","author":"M Farrell","year":"2012","unstructured":"Hedrich D, Alves P, Farrell M, St\u00f6ver H, M\u00f8ller L, Mayet S. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction. 2012;107(3):501\u2013517.","journal-title":"Addiction"},{"key":"352_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2016.1188946","author":"B Zippel-schultz","year":"2016","unstructured":"Zippel-schultz B, Specka M, Cimander K, Eschenhagen T, G\u00f6lz J, Maryschok M, et al. Outcomes of patients in long-term opioid maintenance treatment. Subst Use Misuse. 2016. https:\/\/doi.org\/10.1080\/10826084.2016.1188946.","journal-title":"Subst Use Misuse"},{"key":"352_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-015-0031-4","author":"A Granerud","year":"2015","unstructured":"Granerud A, Toft H. Opioid dependency rehabilitation with the opioid maintenance treatment programme\u2014a qualitative study from the clients \u2019 perspective. Subst Abuse Treat Prev Policy. 2015. https:\/\/doi.org\/10.1186\/s13011-015-0031-4.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"352_CR45","first-page":"172","volume":"15","author":"M Inanlou","year":"2020","unstructured":"Inanlou M, Bahmani B, Farhoudian A, Rafiee F. Addiction recovery: a systematized review. Iran J Psychiatry. 2020;15(2):172\u201381.","journal-title":"Iran J Psychiatry"},{"key":"352_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12954-017-0204-8","volume":"14","author":"A Ghaddar","year":"2017","unstructured":"Ghaddar A, Abbas Z, Haddad R. Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon. Harm Reduct J. 2017;14:78.","journal-title":"Harm Reduct J"},{"issue":"12","key":"352_CR47","doi-asserted-by":"publisher","first-page":"e0244401","DOI":"10.1371\/journal.pone.0244401","volume":"15","author":"D Rice","year":"2020","unstructured":"Rice D, Corace K, Wolfe D, Esmaeilisaraji L, Michaud A, Grima A, et al. Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: a systematic review with network. PLoS ONE. 2020;15(12):e0244401. https:\/\/doi.org\/10.1371\/journal.pone.0244401.","journal-title":"PLoS ONE"},{"issue":"7","key":"352_CR48","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1176\/appi.ps.201400047","volume":"65","author":"S Reif","year":"2014","unstructured":"Reif S, Braude L, Lyman DR, Dougherty RH, Daniels AS, Ghose SS, et al. Peer recovery support for individuals with substance use disorders: assessing the evidence. Psychiatr Serv. 2014;65(7):853\u201361.","journal-title":"Psychiatr Serv"},{"key":"352_CR49","doi-asserted-by":"publisher","first-page":"102604","DOI":"10.1016\/j.drugpo.2019.11.012","volume":"85","author":"AE Rudolph","year":"2020","unstructured":"Rudolph AE, Upton E, McDonald MJ, Young AM, Havens JR. Peer influence of injection drug use cessation among dyads in rural eastern Kentucky. Int J Drug Policy. 2020;85:102604. https:\/\/doi.org\/10.1016\/j.drugpo.2019.11.012.","journal-title":"Int J Drug Policy"},{"key":"352_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/1178221819833379","author":"H Pettersen","year":"2019","unstructured":"Pettersen H, Landheim A, Skeie I, Biong S, Brodahl M, Oute J, et al. How social relationships influence substance use disorder recovery: a collaborative narrative study. Substance Abuse: Treatment and Research, 2019;13:1\u20138. https:\/\/doi.org\/10.1177\/1178221819833379.","journal-title":"Subst Abuse"},{"issue":"2","key":"352_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/ADM.0000000000000555","volume":"14","author":"A Jakubowski","year":"2019","unstructured":"Jakubowski A, Fox A. Defining low-threshold buprenorphine treatment. J Addict Med. 2019;14(2):95\u20138.","journal-title":"J Addict Med"},{"key":"352_CR52","unstructured":"Drug Policy Alliance. A public health and safety approach to problematic opioid use and overdose. 2017;1\u201317. https:\/\/www.drugpolicy.org\/sites\/default\/files\/Opioid_Response_Plan_041817.pdf."},{"issue":"14","key":"352_CR53","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jama.2014.2147","volume":"311","author":"Y Olsen","year":"2014","unstructured":"Olsen Y, Sharfstein J. confronting the stigma of opioid use disorder and its treatment. JAMA. 2014;311(14):1393\u20134.","journal-title":"JAMA"},{"key":"352_CR54","doi-asserted-by":"publisher","first-page":"108276","DOI":"10.1016\/j.jsat.2021.108276","volume":"123","author":"MC Figgatt","year":"2021","unstructured":"Figgatt MC, Salazar Z, Day E, Vincent L, Dasgupta N. Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. J Subst Abuse Treat. 2021;123:108276. https:\/\/doi.org\/10.1016\/j.jsat.2021.108276.","journal-title":"J Subst Abuse Treat"},{"key":"352_CR55","doi-asserted-by":"publisher","first-page":"108154","DOI":"10.1016\/j.jsat.2020.108154","volume":"119","author":"J Trujols","year":"2020","unstructured":"Trujols J, Larrabeiti A, S\u00e0nchez O, Madrid M, De Andr\u00e9s S, Duran-Sindreu S. Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care\u202f? J Subst Abuse Treat. 2020;119:108154. https:\/\/doi.org\/10.1016\/j.jsat.2020.108154.","journal-title":"J Subst Abuse Treat"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-022-00352-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-022-00352-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-022-00352-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T17:17:40Z","timestamp":1671124660000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-022-00352-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1186\/s13722-022-00352-z","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"5 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the University of Nairobi\/Kenyatta National Hospital Ethics Research Committee (P683\/08\/2019) and operational approval was obtained from the Nairobi County Research Committee before the study commenced. Written informed consent was obtained from the participants before enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}